Jordan D. Bryan, Chairman, President and CEO, has filed 41 Form 4 transactions across two companies, but the recent record is dominated by FHN and heavily skewed toward selling. Across all filings, Bryan has reported no open-market purchases (code P), while cumulative sales total approximately $4.37 million. The recent window shows 14 sales against zero buys, and the activity pattern reveals no accumulation bias: recurring open-market sales, option exercises, equity grants, gifts, and automatic tax-withholding dispositions make up the entire picture.
The heaviest cluster came on January 29, 2026, when Bryan filed twelve separate "S" transactions in FHN totaling roughly $2.05 million, with individual sale values ranging from $16,891.60 to $582,859.55, alongside an option exercise (code M) valued at about $1.80 million. That followed a smaller sale on January 22, 2025, of $69,828 and $39,907.76, showing a recurring January disposition. In between, Bryan received zero-value equity awards in February 2025, February 2026, and April 2026, made three no-value gifts in July 2025 and one in December 2025, and recorded "F" transactions — shares withheld to cover taxes — of $772,080.84 on March 3, 2025, $655,195.04 on March 2, 2026, and $1,105,900.80 on May 12, 2026.
The direction is consistent: sales and option-exercise-driven dispositions outnumber purchases at every turn, and the only non-sale transactions are compensatory grants, gifts, or automatic withholdings rather than discretionary buys. The filings do not explain the timing, but the quantitative pattern is clear — a net seller over the past year with no open-market purchases in any of the 41 filings.
AI-assisted summary